Icu Medical Inc/de Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Fuller & Thaler Asset Management, Inc. has disclosed a beneficial ownership of 5.19% of ICU Medical, Inc.'s common stock as of June 30, 2026.
NASDAQ
Janus Henderson Group Ltd. has amended its Schedule 13G filing, reporting a decrease in its beneficial ownership of ICU Medical, Inc. common stock to 11.1%.
NASDAQ
Fuller & Thaler Asset Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.94% of ICU Medical Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.19% of ICU Medical Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.82% of ICU Medical Inc.'s common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership of ICU Medical Inc. common stock following an internal realignment.
NASDAQ
Janus Henderson Group plc and its affiliate Janus Henderson Enterprise Fund have reported beneficial ownership of 10.0% and 5.0% respectively in ICU Medical, Inc. common stock.
NASDAQ
SCHEDULE 13G/A: Janus Henderson Group Discloses 10.0% Stake in ICU Medical, Inc.
Janus Henderson Group PLC has filed an amended Schedule 13G, revealing a beneficial ownership of 10.0% of ICU Medical, Inc.'s common stock as of April 30, 2025.
NASDAQ
Janus Henderson Group PLC and its affiliate, Janus Henderson Enterprise Fund, have disclosed significant beneficial ownership stakes in ICU Medical, Inc. through a Schedule 13G filing.